ProtOS

About

ProtOS is an AI-first protein design company developing therapeutics to treat undruggable diseases. Its transformative approach to protein design leverages proprietary AI models to create novel bio-therapeutics that target previously undruggable pathways, by precisely interacting with proteins-of-interest beyond the reach of small molecules and antibodies. The company has created a robust therapeutic platform to develop Biologic Targeted Protein Degraders. Its SHRED platform uses foundation models to design de-novo AI-proteins that are highly specific and effective in degrading undruggable targets, offering significant advantages over existing PROTAC and Molecular-Glue approaches.

Facts

Funding rounds (1)

Team (2)